SEARCH

SEARCH BY CITATION

References

  • 1
    Gion M, Daidone MG. Circulating biomarkers from tumor bulk to tumor machinery: Promises and pitfalls. Eur J Cancer 2004;40:26132622.
  • 2
    Eisenberg ALA, Koifman S. Breast cancer: Tumor markers. Rev Bras Canc 2001;47:377388.
  • 3
    Jacobs EL, Haskell MC. Clinical use of tumor markers in oncology. Curr Prob Cancer 1991;15:299360.
  • 4
    Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007: Update of recommendations for the use tumor markers in breast cancer. J Clin Oncol 2007;25:52875312.
  • 5
    Molina R, Barak V, Dalen A, et al. Tumor markers in breast cancer – European Group on Tumor Markers recommendations. Tumor Biol 2005;26:281293.
  • 6
    Almeida JRC, Pedrosa NL, Leite JB, et al. Tumor markers: A literature review. Rev Bras Canc 2007;53:305316.
  • 7
    Souza JV. Marker mucinous cancer associated. Rev AMRIGS 2002;46:7083.
  • 8
    von Kleist S, Migule I, Halla B. Possible function of CEA as cell-contact inhibitory molecule. Anticancer Res 1995;15:18891894.
  • 9
    Cheung KL, Graves CRL, Robertson JFR. Tumor marker measurements in the diagnostics, monitoring of breast cancer. Cancer Treat Rev 2000;26:91102.
  • 10
    Duffy M, Duggan C, Keane R, et al. High preoperative CA 15-3 concentrations predict adverse outcome in node-negative and node-positive breast cancer: Study of 600 patients with histologically confirmed breast cancer. Clin Chem 2004;50:559563.
  • 11
    Marchesi MC, Manuali E, Pacifico E, et al. Cancer antigen 15/3: Possible diagnostic use in veterinary clinical oncology. Preliminary study. Vet Res Commun 2010;34:103106.
  • 12
    Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 2006;9:425434.
  • 13
    Koukourakis M, Giatromanolaki A, Sivridis E, et al. Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Brit J Cancer 2003;89:877885.
  • 14
    Peleteiro MC. Tumores mamários na cadela e na gata. Rev Port Cien Vet 1994;89:1034.
  • 15
    Cassali GD, Gobbi H, Malm C, Schimitt FC. Evaluation of accuracy of fine needle aspiration cytology for diagnosis of canine mammary tumours: Comparative features with human tumours. Cytopathology 2007;18 :191196.
  • 16
    Misdorp W. Malignant Mammary tumors in the dog and cat. In: Mouton, DJ. Tumors in Domestic Animals, 4th ed. IA: Blackwell; 2002:589606.
  • 17
    Cavalcanti MF, Cassali GD. Fatores prognósticos no diagnóstico clínico e histopatológico dos tumores de mama em cadelas- revisão. Rev Clin Vet 2006;61:5663.
  • 18
    Perez-Alenza Md, Peña L, Del Castillo N, et al. Factors influencing the incidence and prognosis of canine mammary tumors. J Small Anim Pract 2000;41:287291.
  • 19
    Misdorp W, Else RW, Hellmén E, Limpscomb TP. Histological Classification of Mammary Tumors of the Dog and the Cat. Washington D.C.: World Health Organization; 1999;7:1125.
  • 20
    Kaneko JJ, Harvey JW, Bruss ML. Clinical Biochemistry of Domestic Animals, 5th ed. San Diego: Academic Press; 1997:646879.
  • 21
    Safi F, Kohler I, Rottinger E, Beger HG. The value of the tumor marker CA15.3 in diagnosing and monitoring breast cancer. Cancer 1991:574582.
  • 22
    Balint E, Manolescu N, Braslasu D, et al. Molecular detection through CEA (carcino-embrionic-antigen) of different types of cancer in animal. Lucrări Stiintifice Medicină Veterinară 2008;51:8993.
  • 23
    Waisberg J, Landman G, Cha ASH, et al. Standard of the tecidual distribution of the CEA in the carcinoma col-retal: Relation with the serico level of the CEA and sorting of Dukes. Rev Bras Colo-proctol 2002;22:2026.
  • 24
    Shawn RC, Kevin LB, Bryant SA, et al. Comparative study of four serological tumor markers for the detection of breast cancer. J Miss Acad Sci 2002;47:126128.
  • 25
    Magro AM, Bento RS. Tumour markers. Med Int 1997;4:189196.
  • 26
    Carvalho JLBD. Serum lactate dehydrogenase in neoplastic disease. Pediatria 1993;15:3840.
  • 27
    Giatromanolaki A, Sivridis E, Gatter KC, et al. Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis. Gynecol Oncol 2006;103:912918.
  • 28
    Manuali E, De Giuseppe A, Feliziani F, et al. CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade. BMC Vet Res 2012;8:86.